US FDA grants EUA for Novavax COVID-19 vaccine, adjuvanted for adolescents aged 12 through 17 years EP News Bureau Aug 22, 2022 Novavax vaccine is the first protein-based COVID-19 vaccine authorised in the US
Pfizer, BioNTech get US FDA nod for emergency use of COVID-19 vaccine in adolescents EP News Bureau May 11, 2021 This is the first COVID-19 vaccine authorised in the US for use in this age group
